# Setmelanotide TRANSCEND: hypothalamic obesity interviews

Source: https://pepvault.app/research/setmelanotide-transcend-2026-42528856

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Setmelanotide](https://pepvault.app/research#setmelanotide)

Clinical trial · people

# Setmelanotide: patients reported less hunger, more energy in TRANSCEND

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

For acquired hypothalamic obesity, this study adds patient and caregiver accounts that the benefits people noticed on setmelanotide went beyond weight, to hunger, energy and activity.

- **Kind:** Clinical trial
- **Studied in:** People
- **Number studied:** 30
- **Published:** 2026
- **Journal:** Front Behav Neurosci

## What they tested

The team wanted to learn how people with acquired hypothalamic obesity, and their caregivers, experienced changes in hunger, weight, energy and activity on setmelanotide, and whether those changes mattered to them.

## How the study was done

An interview substudy of the Phase 3 TRANSCEND trial, which was randomized, double-blind and placebo-controlled (placebo, a dummy treatment). Researchers held 75-minute guided interviews with 30 US trial participants or their caregivers between July 2024 and January 2025, then sorted what people said into common themes.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The 30 people interviewed included 16 caregivers and 14 people enrolled in the trial, 10 of them adults and 4 of them teens; setmelanotide was the treatment in 23 cases and placebo in 7. Looking back to the time after their hypothalamic injury and before the trial, every interviewee described hunger that was never satisfied and weight that kept climbing fast, and 29 of 30 described low energy. Those on setmelanotide, and the caregivers of those on it, described gains in hunger, weight, energy and physical activity, and said these gains were meaningful to them. Interviewees from the placebo group described no such changes.

## What it doesn’t show

This was a small interview study of English-speaking US participants, with only 7 on placebo, and it captured what people said rather than measured outcomes. It is a substudy of a larger trial, so it adds personal accounts rather than new measurements.

## The paper

Roth et al. Quality of life improvements with setmelanotide treatment in acquired hypothalamic obesity: TRANSCEND trial interview results from US participants. Front Behav Neurosci. 2026.

- [PubMed (PMID 42528856)](https://pubmed.ncbi.nlm.nih.gov/42528856/)
- [The paper (DOI 10.3389/fnbeh.2026.1830070)](https://doi.org/10.3389/fnbeh.2026.1830070)
- [ClinicalTrials.gov (NCT05774756)](https://clinicaltrials.gov/study/NCT05774756)

## The compound

- [Setmelanotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## More studies on Setmelanotide

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026) Meta-analysis · people · 2026
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026) Randomized trial · people · 2026
- [Setmelanotide: mean BMI fell 18% at 52 weeks in ages 2-5 (VENTURE)](https://pepvault.app/research/setmelanotide-venture-2025) Clinical trial · people · 2025
- [Setmelanotide: 15% mean BMI drop at 16 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-roth-2024) Clinical trial · people · 2024
- [Setmelanotide: quality of life rose after 52 weeks in Bardet-Biedl](https://pepvault.app/research/setmelanotide-forsythe-2023) Clinical trial · people · 2023
- [Setmelanotide: 80% (POMC) and 45% (LEPR) lost at least 10% weight](https://pepvault.app/research/setmelanotide-clement-2020) Clinical trial · people · 2020
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

## The library

- [Setmelanotide](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
